GEMCITABINE (GEMZAR) AS A SALVAGE THERAPY AT RELAPSED AND REFRACTORY HODGKIN'S LYMPHOMA

被引：0
|
作者：
Violeta, V. [1 ]
Jankovic, S. [1 ]
Andjelic, B. [1 ]
Bogunovic, M. [1 ]
Petrovic, M. [1 ]
Mihaljevic, B. [1 ]
机构：
[1] Clin Ctr Serbia, Belgrade, Serbia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：637 / 637
页数：1
相关论文
共 50 条
  • [21] Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
    Hertzberg, M. S.
    Crombie, C.
    Benson, W.
    Taper, J.
    Gottlieb, D.
    Bradstock, K. F.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 25 - 30
  • [22] A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma
    Cohen, Jonathon Brett
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia A.
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Gemcitabine as a single agent in the treatment of relapsed or refractory Hodgkin's and Non Hodgkin's lymphoma.
    Jajeh, A
    Hadad, L
    Godo, C
    Nukala, S
    [J]. BLOOD, 2001, 98 (11) : 242B - 243B
  • [24] Cisplatin-based protocols as salvage therapy for relapsed or refractory Hodgkin's lymphoma patients.
    Alvarez, I
    Sureda, A
    Arranz, R
    Córdoba, R
    Xicoy, B
    Sánchez, B
    Bernal, MT
    Roncero, MIG
    Martí, E
    Pliego, A
    Fernández-Abellán, P
    Ribera, JM
    Fernández-Rañada, JM
    Sierra, J
    [J]. BLOOD, 2005, 106 (11) : 751A - 751A
  • [25] DHAOX AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN'S AND NON HODGKIN'S LYMPHOMAS
    Rigacci, L.
    Fabbri, A.
    Puccini, B.
    Vitolo, U.
    Lenoci, M.
    Mappa, S.
    Chitarrelli, I.
    Levis, A.
    Lauria, F.
    Bosi, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 249 - 249
  • [26] Gemcitabine plus rituximab therapy of patients with relapsed and refractory classical Hodgkin lymphoma.
    Younes, A
    Fayad, L
    Pro, B
    Goy, A
    Romaguera, JE
    Hagemeister, FB
    McLaughlin, P
    [J]. BLOOD, 2005, 106 (11) : 431A - 431A
  • [27] Gemcitabine combined with oxaliplatin in the treatment of relapsed or refractory Hodgkin lymphoma
    Coliat, P.
    El Aatmani, A.
    Berceanu, A.
    Leveque, D.
    Herbrecht, R.
    Beretz, L.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 459 - 459
  • [28] Relapsed/Refractory Hodgkin lymphoma: a 'real world' analysis of salvage therapy in the East of England
    Sarkies, Patrick
    Miller, Jonathan
    Shah, Nimish
    Santarsieri, Anna
    Cooke, Lisa
    Follows, George
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 189 - 190
  • [29] Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin Lymphoma
    Kallam, Avyakta
    Vose, Julie M.
    [J]. ONCOLOGY-NEW YORK, 2019, 33 (05): : 192 - 198
  • [30] Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
    Ulu, Bahar Uncu
    Dal, Mehmet Sinan
    Hindilerden, Ipek Yonal
    Akay, Olga Meltem
    Mehtap, Ozgur
    Buyukkurt, Nurhilal
    Hindilerden, Fehmi
    Gunes, Ahmet Kursad
    Yigenoglu, Tugce Nur
    Basci, Semih
    Cakar, Merih Kizil
    Acik, Didar Yanardag
    Korkmaz, Serdal
    Ulas, Turgay
    Ozet, Gulsum
    Ferhanoglu, Burhan
    Nalcaci, Meliha
    Altuntas, Fevzi
    [J]. JOURNAL OF CHEMOTHERAPY, 2022, 34 (03) : 190 - 198
12345